1 Market Overview

1.1 Product Overview and Scope of Infectious Diseases

1.2 Classification of Infectious Diseases by Type

1.2.1 Overview: Global Infectious Diseases Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Infectious Diseases Revenue Market Share by Type in 2020

1.2.3 Antibacterial Drugs

1.2.4 Antiviral Drugs

1.2.5 Antifungal Drugs

1.2.6 Antiparasitic Drugs

1.3 Global Infectious Diseases Market by Application

1.3.1 Overview: Global Infectious Diseases Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals/Clinical Laboratories

1.3.3 Reference Laboratories

1.3.4 Academic/Research Institutes

1.3.5 Other

1.4 Global Infectious Diseases Market Size & Forecast

1.5 Global Infectious Diseases Market Size and Forecast by Region

1.5.1 Global Infectious Diseases Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Infectious Diseases Market Size by Region, (2016-2021)

1.5.3 North America Infectious Diseases Market Size and Prospect (2016-2026)

1.5.4 Europe Infectious Diseases Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Infectious Diseases Market Size and Prospect (2016-2026)

1.5.6 South America Infectious Diseases Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Infectious Diseases Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Infectious Diseases Market Drivers

1.6.2 Infectious Diseases Market Restraints

1.6.3 Infectious Diseases Trends Analysis

2 Company Profiles

2.1 F. Hoffmann-La Roche

2.1.1 F. Hoffmann-La Roche Details

2.1.2 F. Hoffmann-La Roche Major Business

2.1.3 F. Hoffmann-La Roche Infectious Diseases Product and Solutions

2.1.4 F. Hoffmann-La Roche Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 F. Hoffmann-La Roche Recent Developments and Future Plans

2.2 Gilead Sciences

2.2.1 Gilead Sciences Details

2.2.2 Gilead Sciences Major Business

2.2.3 Gilead Sciences Infectious Diseases Product and Solutions

2.2.4 Gilead Sciences Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Gilead Sciences Recent Developments and Future Plans

2.3 GlaxoSmithKline

2.3.1 GlaxoSmithKline Details

2.3.2 GlaxoSmithKline Major Business

2.3.3 GlaxoSmithKline Infectious Diseases Product and Solutions

2.3.4 GlaxoSmithKline Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 GlaxoSmithKline Recent Developments and Future Plans

2.4 Johnson & Johnson

2.4.1 Johnson & Johnson Details

2.4.2 Johnson & Johnson Major Business

2.4.3 Johnson & Johnson Infectious Diseases Product and Solutions

2.4.4 Johnson & Johnson Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Johnson & Johnson Recent Developments and Future Plans

2.5 Merck

2.5.1 Merck Details

2.5.2 Merck Major Business

2.5.3 Merck Infectious Diseases Product and Solutions

2.5.4 Merck Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Merck Recent Developments and Future Plans

2.6 Pfizer

2.6.1 Pfizer Details

2.6.2 Pfizer Major Business

2.6.3 Pfizer Infectious Diseases Product and Solutions

2.6.4 Pfizer Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Pfizer Recent Developments and Future Plans

2.7 AbbVie

2.7.1 AbbVie Details

2.7.2 AbbVie Major Business

2.7.3 AbbVie Infectious Diseases Product and Solutions

2.7.4 AbbVie Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 AbbVie Recent Developments and Future Plans

2.8 Astellas Pharma

2.8.1 Astellas Pharma Details

2.8.2 Astellas Pharma Major Business

2.8.3 Astellas Pharma Infectious Diseases Product and Solutions

2.8.4 Astellas Pharma Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Astellas Pharma Recent Developments and Future Plans

2.9 AstraZeneca

2.9.1 AstraZeneca Details

2.9.2 AstraZeneca Major Business

2.9.3 AstraZeneca Infectious Diseases Product and Solutions

2.9.4 AstraZeneca Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 AstraZeneca Recent Developments and Future Plans

2.10 Bayer

2.10.1 Bayer Details

2.10.2 Bayer Major Business

2.10.3 Bayer Infectious Diseases Product and Solutions

2.10.4 Bayer Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Bayer Recent Developments and Future Plans

2.11 Bristol-Myers Squibb

2.11.1 Bristol-Myers Squibb Details

2.11.2 Bristol-Myers Squibb Major Business

2.11.3 Bristol-Myers Squibb Infectious Diseases Product and Solutions

2.11.4 Bristol-Myers Squibb Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.12 Chimerix Pharmaceuticals

2.12.1 Chimerix Pharmaceuticals Details

2.12.2 Chimerix Pharmaceuticals Major Business

2.12.3 Chimerix Pharmaceuticals Infectious Diseases Product and Solutions

2.12.4 Chimerix Pharmaceuticals Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Chimerix Pharmaceuticals Recent Developments and Future Plans

2.13 Cubist

2.13.1 Cubist Details

2.13.2 Cubist Major Business

2.13.3 Cubist Infectious Diseases Product and Solutions

2.13.4 Cubist Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Cubist Recent Developments and Future Plans

2.14 Eli Lilly

2.14.1 Eli Lilly Details

2.14.2 Eli Lilly Major Business

2.14.3 Eli Lilly Infectious Diseases Product and Solutions

2.14.4 Eli Lilly Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Eli Lilly Recent Developments and Future Plans

2.15 Isis Pharmaceuticals

2.15.1 Isis Pharmaceuticals Details

2.15.2 Isis Pharmaceuticals Major Business

2.15.3 Isis Pharmaceuticals Infectious Diseases Product and Solutions

2.15.4 Isis Pharmaceuticals Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Isis Pharmaceuticals Recent Developments and Future Plans

2.16 Mitsubishi Tanabe Pharma

2.16.1 Mitsubishi Tanabe Pharma Details

2.16.2 Mitsubishi Tanabe Pharma Major Business

2.16.3 Mitsubishi Tanabe Pharma Infectious Diseases Product and Solutions

2.16.4 Mitsubishi Tanabe Pharma Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Mitsubishi Tanabe Pharma Recent Developments and Future Plans

2.17 Novartis

2.17.1 Novartis Details

2.17.2 Novartis Major Business

2.17.3 Novartis Infectious Diseases Product and Solutions

2.17.4 Novartis Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Novartis Recent Developments and Future Plans

2.18 Sanofi

2.18.1 Sanofi Details

2.18.2 Sanofi Major Business

2.18.3 Sanofi Infectious Diseases Product and Solutions

2.18.4 Sanofi Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Sanofi Recent Developments and Future Plans

2.19 Vertex

2.19.1 Vertex Details

2.19.2 Vertex Major Business

2.19.3 Vertex Infectious Diseases Product and Solutions

2.19.4 Vertex Infectious Diseases Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Vertex Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Infectious Diseases Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Infectious Diseases Players Market Share

3.2.2 Top 10 Infectious Diseases Players Market Share

3.2.3 Market Competition Trend

3.3 Infectious Diseases Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Infectious Diseases Revenue and Market Share by Type (2016-2021)

4.2 Global Infectious Diseases Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Infectious Diseases Revenue Market Share by Application (2016-2021)

5.2 Infectious Diseases Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Infectious Diseases Revenue by Type (2016-2026)

6.2 North America Infectious Diseases Revenue by Application (2016-2026)

6.3 North America Infectious Diseases Market Size by Country

6.3.1 North America Infectious Diseases Revenue by Country (2016-2026)

6.3.2 United States Infectious Diseases Market Size and Forecast (2016-2026)

6.3.3 Canada Infectious Diseases Market Size and Forecast (2016-2026)

6.3.4 Mexico Infectious Diseases Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Infectious Diseases Revenue by Type (2016-2026)

7.2 Europe Infectious Diseases Revenue by Application (2016-2026)

7.3 Europe Infectious Diseases Market Size by Country

7.3.1 Europe Infectious Diseases Revenue by Country (2016-2026)

7.3.2 Germany Infectious Diseases Market Size and Forecast (2016-2026)

7.3.3 France Infectious Diseases Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Infectious Diseases Market Size and Forecast (2016-2026)

7.3.5 Russia Infectious Diseases Market Size and Forecast (2016-2026)

7.3.6 Italy Infectious Diseases Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Infectious Diseases Revenue by Type (2016-2026)

8.2 Asia-Pacific Infectious Diseases Revenue by Application (2016-2026)

8.3 Asia-Pacific Infectious Diseases Market Size by Region

8.3.1 Asia-Pacific Infectious Diseases Revenue by Region (2016-2026)

8.3.2 China Infectious Diseases Market Size and Forecast (2016-2026)

8.3.3 Japan Infectious Diseases Market Size and Forecast (2016-2026)

8.3.4 South Korea Infectious Diseases Market Size and Forecast (2016-2026)

8.3.5 India Infectious Diseases Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Infectious Diseases Market Size and Forecast (2016-2026)

8.3.7 Australia Infectious Diseases Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Infectious Diseases Revenue by Type (2016-2026)

9.2 South America Infectious Diseases Revenue by Application (2016-2026)

9.3 South America Infectious Diseases Market Size by Country

9.3.1 South America Infectious Diseases Revenue by Country (2016-2026)

9.3.2 Brazil Infectious Diseases Market Size and Forecast (2016-2026)

9.3.3 Argentina Infectious Diseases Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Infectious Diseases Revenue by Type (2016-2026)

10.2 Middle East & Africa Infectious Diseases Revenue by Application (2016-2026)

10.3 Middle East & Africa Infectious Diseases Market Size by Country

10.3.1 Middle East & Africa Infectious Diseases Revenue by Country (2016-2026)

10.3.2 Turkey Infectious Diseases Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Infectious Diseases Market Size and Forecast (2016-2026)

10.3.4 UAE Infectious Diseases Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Infectious Diseases Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Infectious Diseases Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Infectious Diseases Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Infectious Diseases Revenue (USD Million) by Region (2016-2021)

Table 5. Global Infectious Diseases Revenue Market Share by Region (2021-2026)

Table 6. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors

Table 7. F. Hoffmann-La Roche Major Business

Table 8. F. Hoffmann-La Roche Infectious Diseases Product and Solutions

Table 9. F. Hoffmann-La Roche Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Gilead Sciences Corporate Information, Head Office, and Major Competitors

Table 11. Gilead Sciences Major Business

Table 12. Gilead Sciences Infectious Diseases Product and Solutions

Table 13. Gilead Sciences Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 15. GlaxoSmithKline Major Business

Table 16. GlaxoSmithKline Infectious Diseases Product and Solutions

Table 17. GlaxoSmithKline Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 19. Johnson & Johnson Major Business

Table 20. Johnson & Johnson Infectious Diseases Product and Solutions

Table 21. Johnson & Johnson Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Merck Corporate Information, Head Office, and Major Competitors

Table 23. Merck Major Business

Table 24. Merck Infectious Diseases Product and Solutions

Table 25. Merck Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Pfizer Corporate Information, Head Office, and Major Competitors

Table 27. Pfizer Major Business

Table 28. Pfizer Infectious Diseases Product and Solutions

Table 29. Pfizer Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. AbbVie Corporate Information, Head Office, and Major Competitors

Table 31. AbbVie Major Business

Table 32. AbbVie Infectious Diseases Product and Solutions

Table 33. AbbVie Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Astellas Pharma Corporate Information, Head Office, and Major Competitors

Table 35. Astellas Pharma Major Business

Table 36. Astellas Pharma Infectious Diseases Product and Solutions

Table 37. Astellas Pharma Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 39. AstraZeneca Major Business

Table 40. AstraZeneca Infectious Diseases Product and Solutions

Table 41. AstraZeneca Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Bayer Corporate Information, Head Office, and Major Competitors

Table 43. Bayer Major Business

Table 44. Bayer Infectious Diseases Product and Solutions

Table 45. Bayer Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 47. Bristol-Myers Squibb Major Business

Table 48. Bristol-Myers Squibb Infectious Diseases Product and Solutions

Table 49. Bristol-Myers Squibb Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Chimerix Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 51. Chimerix Pharmaceuticals Major Business

Table 52. Chimerix Pharmaceuticals Infectious Diseases Product and Solutions

Table 53. Chimerix Pharmaceuticals Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Cubist Corporate Information, Head Office, and Major Competitors

Table 55. Cubist Major Business

Table 56. Cubist Infectious Diseases Product and Solutions

Table 57. Cubist Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 59. Eli Lilly Major Business

Table 60. Eli Lilly Infectious Diseases Product and Solutions

Table 61. Eli Lilly Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Isis Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 63. Isis Pharmaceuticals Major Business

Table 64. Isis Pharmaceuticals Infectious Diseases Product and Solutions

Table 65. Isis Pharmaceuticals Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Mitsubishi Tanabe Pharma Corporate Information, Head Office, and Major Competitors

Table 67. Mitsubishi Tanabe Pharma Major Business

Table 68. Mitsubishi Tanabe Pharma Infectious Diseases Product and Solutions

Table 69. Mitsubishi Tanabe Pharma Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Novartis Corporate Information, Head Office, and Major Competitors

Table 71. Novartis Major Business

Table 72. Novartis Infectious Diseases Product and Solutions

Table 73. Novartis Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Sanofi Corporate Information, Head Office, and Major Competitors

Table 75. Sanofi Major Business

Table 76. Sanofi Infectious Diseases Product and Solutions

Table 77. Sanofi Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Vertex Corporate Information, Head Office, and Major Competitors

Table 79. Vertex Major Business

Table 80. Vertex Infectious Diseases Product and Solutions

Table 81. Vertex Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Global Infectious Diseases Revenue (USD Million) by Players (2019-2021)

Table 83. Global Infectious Diseases Revenue Share by Players (2019-2021)

Table 84. Breakdown of Infectious Diseases by Company Type (Tier 1, Tier 2 and Tier 3)

Table 85. Infectious Diseases Players Head Office, Products and Services Provided

Table 86. Infectious Diseases Mergers & Acquisitions in the Past Five Years

Table 87. Infectious Diseases New Entrants and Expansion Plans

Table 88. Global Infectious Diseases Revenue (USD Million) by Type (2016-2021)

Table 89. Global Infectious Diseases Revenue Share by Type (2016-2021)

Table 90. Global Infectious Diseases Revenue Forecast by Type (2021-2026)

Table 91. Global Infectious Diseases Revenue by Application (2016-2021)

Table 92. Global Infectious Diseases Revenue Forecast by Application (2021-2026)

Table 93. North America Infectious Diseases Revenue by Type (2016-2021) & (USD Million)

Table 94. North America Infectious Diseases Revenue by Type (2021-2026) & (USD Million)

Table 95. North America Infectious Diseases Revenue by Application (2016-2021) & (USD Million)

Table 96. North America Infectious Diseases Revenue by Application (2021-2026) & (USD Million)

Table 97. North America Infectious Diseases Revenue by Country (2016-2021) & (USD Million)

Table 98. North America Infectious Diseases Revenue by Country (2021-2026) & (USD Million)

Table 99. Europe Infectious Diseases Revenue by Type (2016-2021) & (USD Million)

Table 100. Europe Infectious Diseases Revenue by Type (2021-2026) & (USD Million)

Table 101. Europe Infectious Diseases Revenue by Application (2016-2021) & (USD Million)

Table 102. Europe Infectious Diseases Revenue by Application (2021-2026) & (USD Million)

Table 103. Europe Infectious Diseases Revenue by Country (2016-2021) & (USD Million)

Table 104. Europe Infectious Diseases Revenue by Country (2021-2026) & (USD Million)

Table 105. Asia-Pacific Infectious Diseases Revenue by Type (2016-2021) & (USD Million)

Table 106. Asia-Pacific Infectious Diseases Revenue by Type (2021-2026) & (USD Million)

Table 107. Asia-Pacific Infectious Diseases Revenue by Application (2016-2021) & (USD Million)

Table 108. Asia-Pacific Infectious Diseases Revenue by Application (2021-2026) & (USD Million)

Table 109. Asia-Pacific Infectious Diseases Revenue by Region (2016-2021) & (USD Million)

Table 110. Asia-Pacific Infectious Diseases Revenue by Region (2021-2026) & (USD Million)

Table 111. South America Infectious Diseases Revenue by Type (2016-2021) & (USD Million)

Table 112. South America Infectious Diseases Revenue by Type (2021-2026) & (USD Million)

Table 113. South America Infectious Diseases Revenue by Application (2016-2021) & (USD Million)

Table 114. South America Infectious Diseases Revenue by Application (2021-2026) & (USD Million)

Table 115. South America Infectious Diseases Revenue by Country (2016-2021) & (USD Million)

Table 116. South America Infectious Diseases Revenue by Country (2021-2026) & (USD Million)

Table 117. Middle East & Africa Infectious Diseases Revenue by Type (2016-2021) & (USD Million)

Table 118. Middle East & Africa Infectious Diseases Revenue by Type (2021-2026) & (USD Million)

Table 119. Middle East & Africa Infectious Diseases Revenue by Application (2016-2021) & (USD Million)

Table 120. Middle East & Africa Infectious Diseases Revenue by Application (2021-2026) & (USD Million)

Table 121. Middle East & Africa Infectious Diseases Revenue by Country (2016-2021) & (USD Million)

Table 122. Middle East & Africa Infectious Diseases Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Infectious Diseases Picture

Figure 2. Global Infectious Diseases Revenue Market Share by Type in 2020

Figure 3. Antibacterial Drugs

Figure 4. Antiviral Drugs

Figure 5. Antifungal Drugs

Figure 6. Antiparasitic Drugs

Figure 7. Infectious Diseases Revenue Market Share by Application in 2020

Figure 8. Hospitals/Clinical Laboratories Picture

Figure 9. Reference Laboratories Picture

Figure 10. Academic/Research Institutes Picture

Figure 11. Other Picture

Figure 12. Global Infectious Diseases Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global Infectious Diseases Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global Infectious Diseases Revenue Market Share by Region (2016-2026)

Figure 15. Global Infectious Diseases Revenue Market Share by Region in 2020

Figure 16. North America Infectious Diseases Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe Infectious Diseases Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific Infectious Diseases Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America Infectious Diseases Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa Infectious Diseases Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Infectious Diseases Market Drivers

Figure 22. Infectious Diseases Market Restraints

Figure 23. Infectious Diseases Market Trends

Figure 24. F. Hoffmann-La Roche Recent Developments and Future Plans

Figure 25. Gilead Sciences Recent Developments and Future Plans

Figure 26. GlaxoSmithKline Recent Developments and Future Plans

Figure 27. Johnson & Johnson Recent Developments and Future Plans

Figure 28. Merck Recent Developments and Future Plans

Figure 29. Pfizer Recent Developments and Future Plans

Figure 30. AbbVie Recent Developments and Future Plans

Figure 31. Astellas Pharma Recent Developments and Future Plans

Figure 32. AstraZeneca Recent Developments and Future Plans

Figure 33. Bayer Recent Developments and Future Plans

Figure 34. Bristol-Myers Squibb Recent Developments and Future Plans

Figure 35. Chimerix Pharmaceuticals Recent Developments and Future Plans

Figure 36. Cubist Recent Developments and Future Plans

Figure 37. Eli Lilly Recent Developments and Future Plans

Figure 38. Isis Pharmaceuticals Recent Developments and Future Plans

Figure 39. Mitsubishi Tanabe Pharma Recent Developments and Future Plans

Figure 40. Novartis Recent Developments and Future Plans

Figure 41. Sanofi Recent Developments and Future Plans

Figure 42. Vertex Recent Developments and Future Plans

Figure 43. Global Infectious Diseases Revenue Share by Players in 2020

Figure 44. Infectious Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 45. Global Top 3 Players Infectious Diseases Revenue Market Share in 2020

Figure 46. Global Top 10 Players Infectious Diseases Revenue Market Share in 2020

Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 48. Global Infectious Diseases Revenue Share by Type in 2020

Figure 49. Global Infectious Diseases Market Share Forecast by Type (2021-2026)

Figure 50. Global Infectious Diseases Revenue Share by Application in 2020

Figure 51. Global Infectious Diseases Market Share Forecast by Application (2021-2026)

Figure 52. North America Infectious Diseases Sales Market Share by Type (2016-2026)

Figure 53. North America Infectious Diseases Sales Market Share by Application (2016-2026)

Figure 54. North America Infectious Diseases Revenue Market Share by Country (2016-2026)

Figure 55. United States Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Canada Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Mexico Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Europe Infectious Diseases Sales Market Share by Type (2016-2026)

Figure 59. Europe Infectious Diseases Sales Market Share by Application (2016-2026)

Figure 60. Europe Infectious Diseases Revenue Market Share by Country (2016-2026)

Figure 61. Germany Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. France Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. United Kingdom Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Russia Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Italy Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Asia-Pacific Infectious Diseases Sales Market Share by Type (2016-2026)

Figure 67. Asia-Pacific Infectious Diseases Sales Market Share by Application (2016-2026)

Figure 68. Asia-Pacific Infectious Diseases Revenue Market Share by Region (2016-2026)

Figure 69. China Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Japan Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. South Korea Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. India Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Southeast Asia Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Australia Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. South America Infectious Diseases Sales Market Share by Type (2016-2026)

Figure 76. South America Infectious Diseases Sales Market Share by Application (2016-2026)

Figure 77. South America Infectious Diseases Revenue Market Share by Country (2016-2026)

Figure 78. Brazil Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Argentina Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Middle East and Africa Infectious Diseases Sales Market Share by Type (2016-2026)

Figure 81. Middle East and Africa Infectious Diseases Sales Market Share by Application (2016-2026)

Figure 82. Middle East and Africa Infectious Diseases Revenue Market Share by Country (2016-2026)

Figure 83. Turkey Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. Saudi Arabia Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. UAE Infectious Diseases Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 86. Methodology

Figure 87. Research Process and Data Source